Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aliskiren regimen in patients with severe hypertension
jRCT2080220236Phase 3
- Sponsor
- Novartis
- Start
- Apr 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of aliskiren in hypertension (HTN), sponsored by Novartis.
02
Drugs
aliskiren
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on jRCT2080220236.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080220236.